Effects of low-dose subcutaneous heparin on the occurrence of deep vein thrombosis in patients with ischemic stroke
Acta Neurologica ScandinavicaPublished 29 January 2009
H. J. Gelmers
Citations47
SJR quartileQ1
SJR score0.95
SNIP1.04
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The effectiveness of low‐dose subcutaneous heparin in the prophylaxis of deep vein thrombosis in patients with ischemic stroke was investigated in an unblinded controlled study.
Abstract
The effectiveness of low-dose subcutaneous heparin in the prophylaxis of deep vein thrombosis in patients with ischemic stroke was investigated in an unblinded controlled study. The frequency of deep vein thrombosis and pulmonary embolism in the control group was 23% versus 2% in the patients receiving heparin. There were no bleeding complications in the test group and there were no differences in the occurrence of hemorrhage changes in the cerebral ischemic infarction in both groups.
Keywords
Medicine
American Journal of Clinical PathologyThe Partial Thromboplastin Time with Kaolin: A Simple Screening Test for First Stage Plasma Clotting Factor Deficiencies
997 Citations1961Robert R. Proctor, Samuel I. Rapaport
Waaler has demonstrated that long times with normal plasma may be caused by inadequate contact activation of the test plasma when, and it is shown that the partial thromboplastin time technic is not widely used in clinical laboratories.
The LancetNATURAL HISTORY OF POSTOPERATIVE DEEP-VEIN THROMBOSIS
904 Citations1969V V Kakkar, C T Howe +2 more
132 consecutive patients were investigated during the postoperative period using the 125 I-labelled fibrinogen test to detect deep-vein thrombosis in the legs to indicate which patients are at risk and which require active treatment.
Journal of Clinical PathologyHUMAN BLOOD COAGULATION AND ITS DISORDERS
360 Citations1963Jane Stafford
The LancetEFFICACY OF LOW DOSES OF HEPARIN IN PREVENTION OF DEEP-VEIN THROMBOSIS AFTER MAJOR SURGERY
302 Citations1972V V Kakkar, J Spindler +6 more
The prophylactic efficacy of " low-dose " heparin was investigated in 78 " high-risk " patients over the age of forty undergoing major surgery, and the difference between these two frequencies was statistically significant.
The LancetLOW DOSES OF HEPARIN IN PREVENTION OF DEEP-VEIN THROMBOSIS
252 Citations1971V V Kakkar, Andrew Nicolaides +4 more
The effectiveness of subcutaneous heparin in the prophylaxis of deep-vein thrombosis was investigated in 53 consecutive patients over the age of 50 undergoing repair of inguinal hernia.
The LancetLOW-DOSE HEPARIN AS A PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER ACUTE STROKE
198 Citations1977Sharon McCarthy, Derrick Robertson +3 more
A trial of subcutaneous low-dose heparin in the prevention of deep-vein thrombosis was carried out in elderly patients admitted to hospital after an acute stroke and a statistically significant reduction was observed inDeep Vein ThromBosis as assessed by isotope leg scanning.
The LancetPREVENTION OF FATAL POSTOPERATIVE THROMBOEMBOLISM BY HEPARIN PROPHYLAXIS
130 Citations1970J. G. Sharnoff
In each of the only 2 instances where excessive bleeding at operation was attributed to heparin, this complication was traced to inadvertently incorrect administration of the anticoagulant.
RadiologyRadioactive Albumin Microspheres for Studies of the Pulmonary Circulation
121 Citations1969Buck A. Rhodes, I. Zolle +2 more
The most common radiopharmaceutical for determining the distribution of pulmonary arterial blood flow is 131 -labeled macroaggregates of human serum albumin, but more recently both 113mIn-labeled floes of iron hydroxide and 99mTc- labeled MAA have also been used.
Annals of Internal MedicineSurgical and Anticoagulant Therapy of Occlusive Cerebrovascular Disease
103 Citations1963Robert G. Siekert, JACK P. WHISNANT +1 more
In recent years the use of anticoagulant therapy and surgical therapy has been advocated for certain varieties of occlusive (ischemic) cerebrovascular disease.
Journal of neurosurgerySafety of mini-dose heparin administration for neurosurgical patients
97 Citations1977Hugh G. Barnett, John R. Clifford +1 more
Although no conclusions were drawn as to the effectiveness of mini-dose heparin in preventing deep venous thrombosis or pulmonary emboli, it was believed that the method could be used safely and without fear of increased intracranial or intraspinal bleeding for neurosurgical patients.
Journal of neurosurgeryIncidence of postoperative deep vein thrombosis in neurosurgical patients
84 Citations1975Stephen N. Joffe
This preliminary report on the use of 123I-fibrinogen and Doppler ultrasound techniques for the diagnosis of postoperative deep vein thrombosis (DVT), shows that neurosurgical patients are at considerable risk of DVT.
The LancetEFFECT OF SMALL DOSES OF HEPARIN ON PLATELET ADHESIVENESS AND LIPOPROTEIN-LIPASE ACTIVITY BEFORE AND AFTER SURGERY
47 Citations1971David Negus, Donald Pinto +1 more
Although it is not certain that a reduction in platelet adhesiveness would affect the incidence of deep-vein thrombosis after surgery, a clinical trial of the smaller dose of heparin would seem worth while for, in respect of effect on coagulability, 1 I.U.Heparin per kg.
StrokeStroke and Blood Coagulation
40 Citations1973Margaret Todd, Ellen McDevitt +1 more
Differences were detected between normals versus patients with thrombotic stroke and patients with diabetes mellitus, but the clinical significance of these differences is not of practical value in the diagnosis or as a guide to therapy for stroke.
StrokeA Study of Blood Coagulation Following an Acute Stroke
34 Citations1971Lamont W. Gaston, John E. Brooks +2 more
A battery of blood coagulation tests were performed on 14 acute stroke patients, notably elevation of blood fibrinogen, factor VIII, prothrombin, platelet factor 3, and a shortened P.T.T., and similar changes were noted in the blood of healthy subjects of the same age range.
StrokeEvidence for Abnormalities in Clotting and Thrombolysis as a Risk Factor For Stroke
34 Citations1973Laurence O. Pilgeram, Anthony N. C. Chee +1 more
Four hundred six patients with ischemic thrombotic cerebrovascular disease (ITCVD) and 115 age-matched controls were studied to select risk factors which would identify ITCVD-prone individuals from a healthy population.
American Heart JournalLow-dose heparin prophylaxis of venous thrombosis: An editorial
10 Citations1979F. William Blaisdell